CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia
CD69 表达可能预测对苯达莫司汀的反应,而依鲁替尼或艾德拉利西布对其的调节可增强慢性淋巴细胞白血病的细胞毒作用
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.6685
Arnau Montraveta, Eriong Lee-Vergés, Jocabed Roldán, Laura Jiménez, Sandra Cabezas, Guillem Clot, Magda Pinyol, Sílvia Xargay-Torrent, Laia Rosich, Cristina Arimany-Nardí, Marta Aymerich, Neus Villamor, Armando López-Guillermo, Patricia Pérez-Galán, Gaël Roué, Marçal Pastor-Anglada, Elías Campo, Món